2026· Advances in Protein Chemistry and Structural Biology· Vol 153, pp.
1-57
· 0 citations
Medicine
TL;DR
This chapter highlights the role of targeting ligands, stimuli-responsive systems, and tumor microenvironment-specific strategies in enhancing therapeutic efficacy while minimizing adverse effects, emphasizing the potential of molecularly targeted nanomedicine to advance precision therapy and improve clinical outcomes.
Overall, cancer nanomedicine has evolved from a simple drug-delivery concept into a multifunctional therapeutic platform integrating targeted therapy, molecular imaging, immunomodulation, gene therapy, and personalized medicine.
Fouzan Arif Mulla Mulla, M. Khan, Irfan Nizamuddin Mansuri Mansuri et al.· Journal of Pharmacology, Gen...· 0 citations
Current preclinical evidence supports nanomedicine as a central pillar of precision drug delivery, with future progress expected to focus on adaptive, multifunctional, and patient-specific platforms that align with the principles of personalized medicine.
Ashna Sureshkumar, Prakash Balu· Frontiers in Biomaterials Sc...· 0 citations
The mini-review outlines the development of active targeting approaches, recent progress in the design of intelligent nanomedicine empowered by biomarkers, selected clinical advances, current clinical trials, and future prospects that could expedite the clinical translation of precision nanomedicine to the mainstream c...
M. Karthick, Rajesh Akkena, K. Loganathan· BOHR Journal of Pharmaceutic...· 0 citations
This review paper provides an integrated and critical perspective on next-generation nanomedicine by connecting nanocarrier design with tumor-specific accumulation, intracellular trafficking, stimuli-responsive drug release, combination therapy and clinical translation.
Biswajit Mohanty, P. Saikia, Piyush Pandey et al.· Frontiers in Chemistry· 0 citations
This review comprehensively examines major nanocarrier platforms, including lipid-based, polymeric, inorganic, and hybrid systems, with emphasis on their structural design and functional properties.
Nithya Ajay, Anu Shibi Anilkumar, R. Veerabathiran· Therapeutic delivery· 0 citations
Novel NCs like microemulsions, vesicular (liposomes), and nanoparticular NCs are created and explored, which have unique improved penetration and retention in the tumour tissue.
Shalu Tiwari, Abhijeet Ojha, A. Singh et al.· Journal of Drug Delivery and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.